₹1,169.70
−2.46%NSE close, 16 Nov 2026
+51.09%
Sudeep Pharma is a small cap company in the Chemicals sector, listed on NSE under the symbol SUDEEPPHRM. At ₹1,169.70 a share, the market values the whole company at ₹13,212 crore.
In FY26, it reported sales of ₹642 crore and a net profit of ₹173 crore, an operating margin of 34.5%.
The market values the company at 94.9 times its profit over the last twelve months and 13.80 times its book value; its return on equity is 14.5% and its borrowings are 0.20 times its equity.
Promoters hold 76.15% of the shares. Foreign institutions hold 2.93%, and domestic institutions, mutual funds among them, 14.05%.
Companies of a similar size in the same sector include Tata Chemicals, Atul, Anupam Rasayan India and Chambal Fertilizers & Chemicals.
₹ crore. Consolidated figures.
The same sector (Chemicals), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Sudeep Pharma | ₹1,169.70 | ₹13,212 cr | 94.9 | 14.5% | +20.90% | n/a |
| Tata Chemicals | ₹612.10 | ₹15,594 cr | n/a | -10.8% | +7.70% | −29.87% |
| Atul | ₹5,130.50 | ₹15,105 cr | 19.6 | 11.7% | +21.00% | −10.94% |
| Anupam Rasayan India | ₹1,316.80 | ₹14,992 cr | 83.1 | 3.6% | +10.20% | +23.24% |
| Chambal Fertilizers & Chemicals | ₹371.50 | ₹14,884 cr | 7.8 | 16.8% |
Transcript
Link of Recording
| 123 |
| Operating profit | 55.5 | 60.0 | 62.6 | 54.9 | 73.2 |
|---|
| Operating margin | 34.1% | 34.8% | 34.3% | 34.7% | 37.2% |
|---|
| Other income | 10.2 | 6.8 | 6.4 | 5.5 | 6.0 |
|---|
| Interest | 2.3 | 1.2 | 2.4 | 2.1 | 2.8 |
|---|
| Depreciation | 3.8 | 3.9 | 3.9 | 4.0 | 5.4 |
|---|
| Profit before tax | 59.5 | 61.8 | 62.7 | 54.3 | 71.0 |
|---|
| Tax | 12.8 | 14.1 | 14.2 | 13.7 | 19.2 |
|---|
| Net profit | 45.8 | – | 48.9 | 40.6 | 51.8 |
|---|
| EPS (₹) | 4.20 | – | 4.38 | 3.59 | 4.59 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 642 |
| Expenses | 420 |
| Operating profit | 222 |
| Operating margin | 34.5% |
| Other income | 28.6 |
| Interest | 7.6 |
| Depreciation | 14.8 |
| Profit before tax | 228 |
| Tax | 53.8 |
| Net profit | 173 |
| EPS (₹) | 15.50 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 69.6 | 43.5 |
| From investing | −327 | −32.9 |
| From financing | 247 | 16.1 |
| Spent on fixed assets | −118 | −0.2 |
| Free cash flow | −48.6 | 43.3 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 26.9% |
| Operating margin | 34.5% |
| Return on equity | 19.6% |
| Return on capital employed | 22.8% |
| Return on assets | 14.7% |
| Debt to equity | 0.17 |
| Interest coverage | 31.00 |
| Debt to assets | 0.13 |
| Current ratio | 3.09 |
| Quick ratio | 2.02 |
| Cash ratio | 0.13 |
| Asset turnover | 0.55 |
| Fixed asset turnover | 2.87 |
| Inventory turnover | 1.10 |
| Receivables turnover | 2.80 |
| Gross margin | 64.6% |
| Cash from operations to profit | 40.0% |
| Effective tax rate | 23.6% |
| +9.10% |
| −23.35% |
| Paradeep Phosphates | ₹136.82 | ₹14,209 cr | 16.7 | 11.9% | +7.20% | −16.48% |
|---|
| Supreme Petrochem | ₹701.55 | ₹13,192 cr | 24.8 | 20.8% | +77.50% | +5.15% |
|---|
| Privi Speciality Chemicals | ₹3,363.90 | ₹13,140 cr | 35.2 | 23.7% | +12.00% | +2.56% |
|---|
| PCBL Chemical | ₹277.30 | ₹10,911 cr | 40.2 | 6.7% | +14.40% | −21.93% |
|---|
Press Release - FDA approval for the new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat,
Schedule of meet
Schedule of meet
General Update
A copy Srutinizers report of Annual General Meeting held on August 04, 2026. Further, the company has informed the Exchange regarding voting results.
The financial results for the period ended Jun 30, 2026.
Proceedings of Annual General Meeting held on August 04, 2026
Record date for the purpose of Dividend is 23-Jul-2026.